Celltrion
068270.KS
#764
Rank
โ‚ฌ29.53 B
Marketcap
128,77ย โ‚ฌ
Share price
4.73%
Change (1 day)
20.19%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): 2,19ย โ‚ฌ

According to Celltrion 's latest financial reports the company's current EPS (TTM) is 2,19ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 2,68ย โ‚ฌ an increase over its 2024 EPS that were of 1,02ย โ‚ฌ.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)2,19ย โ‚ฌ-18.33%
20252,68ย โ‚ฌ163.66%
20241,02ย โ‚ฌ-53.73%
20232,19ย โ‚ฌ-2.08%
20222,24ย โ‚ฌ-11.72%
20212,54ย โ‚ฌ2.03%
20202,49ย โ‚ฌ82.8%
20191,36ย โ‚ฌ18.31%
20181,15ย โ‚ฌ-36.33%
20171,81ย โ‚ฌ161.25%
20160,69ย โ‚ฌ2.86%
20150,67ย โ‚ฌ17.84%
20140,57ย โ‚ฌ5.87%
20130,54ย โ‚ฌ-70.85%
20121,85ย โ‚ฌ134.09%
20110,79ย โ‚ฌ43.59%
20100,55ย โ‚ฌ74.49%
20090,32ย โ‚ฌ317.8%
20080,07546ย โ‚ฌ-71.7%
20070,27ย โ‚ฌ